CTD Announces Partnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States

Press/Media: Press / Media

PeriodNov 8 2018

Media coverage

22

Media coverage

  • TitleCTD Announces Partnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States
    Media name/outletTMC Net
    CountryUnited States
    Date11/8/18
    PersonsDarius Adams
  • TitleCTD Announces Partnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States
    Media name/outletNasdaq
    CountryUnited States
    Date11/8/18
    PersonsDarius Adams
  • TitlePartnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States
    Media name/outletMarket News Publishing
    CountryUnited States
    Date11/8/18
    PersonsDarius Adams
  • TitleCTD Announces Partnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States
    Media name/outletIndia Pharma News
    CountryIndia
    Date11/8/18
    PersonsDarius Adams
  • TitlePartnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States
    Media name/outletMarket News Publishing
    CountryUnited States
    Date11/8/18
    PersonsDarius Adams
  • TitleCTD Announces Partnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States
    Media name/outletSPi World News
    CountryUnited Kingdom
    Date11/8/18
    PersonsDarius Adams
  • TitleCTD Announces Partnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States
    Media name/outletEuroInvestor
    CountryDenmark
    Date11/8/18
    PersonsDarius Adams
  • TitleCTD Announces Partnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States
    Media name/outletMarketScreener.com
    CountryUnited States
    Date11/8/18
    PersonsDarius Adams
  • TitleCTD Announces Partnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States
    Media name/outletStockwatch
    CountryCanada
    Date11/8/18
    PersonsDarius Adams
  • TitleCTD Announces Partnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States
    Media name/outletCustomer Zone 360.com
    CountryUnited States
    Date11/8/18
    PersonsDarius Adams
  • TitleCTD Announces Partnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States
    Media name/outletBiotechgate
    CountrySwitzerland
    Date11/8/18
    PersonsDarius Adams
  • TitleCTD Announces Partnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States
    Media name/outletValuespectrum.com
    CountryUnited States
    Date11/8/18
    PersonsDarius Adams
  • TitleCTD Announces Partnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States
    Media name/outletPrimeNewswire (Top News)
    CountryUnited States
    Date11/8/18
    PersonsDarius Adams
  • TitleCTD Announces Partnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States
    Media name/outletPrimeNewswire (XML)
    CountryUnited States
    Date11/8/18
    PersonsDarius Adams
  • TitleCTD Announces Partnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States
    Media name/outletPlus Company Updates (PCU)
    CountryUnited States
    Date11/8/18
    PersonsDarius Adams
  • TitleCTD Announces Partnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States
    Media name/outletNEMS 360
    CountryUnited States
    Date11/8/18
    PersonsDarius Adams
  • TitleCTD Announces Partnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States
    Media name/outletOmaha World-Herald
    CountryUnited States
    Date11/8/18
    PersonsDarius Adams
  • TitleCTD Announces Partnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States
    Media name/outletYuma Sun
    CountryUnited States
    Date11/8/18
    PersonsDarius Adams
  • TitleCTD Announces Partnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States
    Media name/outletPost Register
    CountryUnited States
    Date11/8/18
    PersonsDarius Adams
  • TitleCTD Announces Partnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States
    Media name/outletGlobeNewswire
    CountryUnited States
    Date11/8/18
    PersonsDarius Adams
  • TitleCTD Announces Partnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States
    Media name/outletBizWire Express
    CountryIndia
    Date11/8/18
    PersonsDarius Adams
  • TitleCTD Announces Partnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States
    Media name/outletEIN News
    CountryUnited States
    Date11/8/18
    PersonsDarius Adams